Holen Sie sich die Stockscreener-App
2.42
0.83%
0.02
Schlusskurs vom Vortag:
$2.40
Offen:
$2.38
24-Stunden-Volumen:
63,251
Relative Volume:
0.37
Marktkapitalisierung:
$100.96M
Einnahmen:
$6.21M
Nettoeinkommen (Verlust:
$-19.92M
KGV:
-2.3048
EPS:
-1.05
Netto-Cashflow:
$-16.76M
1W Leistung:
+0.00%
1M Leistung:
-2.81%
6M Leistung:
-13.57%
1J Leistung:
-7.98%
1-Tages-Spanne:
$2.337
$2.45
1-Wochen-Bereich:
$2.337
$2.45
52-Wochen-Spanne:
$1.99
$3.798
InspireMD Inc. Stock (NSPR) Company Profile
Firmenname
InspireMD Inc.
Sektor
Branche
Telefon
972 3 6917691
Adresse
4 Menorat Hamaor Street, Tel Aviv
Vergleichen Sie NSPR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
2.42 | 100.13M | 6.21M | -19.92M | -16.76M | -1.05 |
|
ABT
Abbott Laboratories
|
134.57 | 233.52B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
98.23 | 145.95B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
377.84 | 144.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.59 | 121.32B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
74.55 | 44.15B | 5.69B | 1.41B | 577.90M | 6.95 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2016-01-07 | Eingeleitet | Rodman & Renshaw | Buy |
| 2015-03-13 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2013-11-26 | Eingeleitet | Oppenheimer | Outperform |
InspireMD Inc. Aktie (NSPR) Neueste Nachrichten
Sell Signal: Can InspireMD Inc outperform in the next rallyQuarterly Risk Review & Risk Controlled Stock Pick Alerts - khodrobank.com
Real time pattern detection on InspireMD Inc. stock2025 Market Overview & Real-Time Volume Analysis - newser.com
New Highs: Can InspireMD Inc. keep up with sector leadersJuly 2025 Big Picture & Daily Volume Surge Signals - khodrobank.com
Block Trades: Is InspireMD Inc part of any ETFMarket Sentiment Summary & Free Fast Entry Momentum Trade Alerts - khodrobank.com
Can machine learning forecast InspireMD Inc. recoveryMarket Growth Summary & Stock Portfolio Risk Management - newser.com
Applying Wyckoff theory to InspireMD Inc. stock2025 Geopolitical Influence & Daily Stock Trend Watchlist - newser.com
What does recent volatility data suggest for InspireMD Inc.Index Update & Low Risk High Reward Ideas - newser.com
Key resistance and support levels for InspireMD Inc.July 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com
InspireMD, Inc. (NYSE:NSPR) Sees Large Decrease in Short Interest - MarketBeat
What momentum shifts mean for InspireMD Inc.Entry Point & Scalable Portfolio Growth Ideas - newser.com
Published on: 2025-09-17 21:49:04 - خودرو بانک
InspireMD Appoints Dan Dearen to Board of Directors - TipRanks
InspireMD adds former Axonics executive Dan Dearen to board - Investing.com
InspireMD, Inc. Announces Appointment of Dan Dearen to Its Board of Directors - MarketScreener
Trade Recap: What analysts say about KALU stockMarket Risk Summary & Reliable Entry Point Alerts - خودرو بانک
InspireMD Announces The Appointment Of Dan Dearen To Its Board Of Directors - TradingView
InspireMD Appoints Dan Dearen to Board of Directors, Strengthening Leadership for Growth Strategy - Quiver Quantitative
InspireMD Announces the Appointment of Dan Dearen to its Board of Directors - GlobeNewswire
Former $3.7B Axonics Success Story: MedTech Veteran Dan Dearen Joins InspireMD's Board Post-FDA Win - Stock Titan
Ranking InspireMD Inc. among high performing stocks via tools2025 Biggest Moves & AI Powered Buy and Sell Recommendations - newser.com
Entry Recap: Is DRTSW in a long term uptrendMarket Growth Review & Fast Exit/Entry Strategy Plans - خودرو بانک
Combining machine learning predictions for InspireMD Inc.Trade Entry Report & AI Enhanced Market Trend Forecasts - newser.com
Analyzing InspireMD Inc. with risk reward ratio charts2025 Technical Overview & Low Drawdown Investment Strategies - newser.com
Analyzing net buyer seller activity in InspireMD Inc.July 2025 PostEarnings & AI Based Buy/Sell Signal Reports - newser.com
Market Fear: Can InspireMD Inc ride the EV waveJuly 2025 Momentum & AI Driven Stock Price Forecasts - خودرو بانک
Long term hold vs stop loss in InspireMD Inc.2025 Key Lessons & Free Verified High Yield Trade Plans - newser.com
Risk Report: Why is InspireMD Inc stock going upMarket Sentiment Summary & Stock Timing and Entry Methods - khodrobank.com
Retail Trends: What is InspireMD Inc. s debt to equity ratio2025 Market Trends & High Win Rate Trade Alerts - khodrobank.com
Signal strength of InspireMD Inc. stock in tech scannersJuly 2025 Opening Moves & Low Risk Entry Point Guides - newser.com
Bond Watch: Is InspireMD Inc. stock undervalued right nowJuly 2025 Weekly Recap & High Return Trade Guides - khodrobank.com
Visual analytics tools that track InspireMD Inc. performanceQuarterly Profit Summary & High Conviction Buy Zone Picks - newser.com
Aug Big Picture: Can InspireMD Inc outperform in the next rallyMarket Sentiment Report & AI Enhanced Execution Alerts - khodrobank.com
Will InspireMD Inc. benefit from macro trends2025 Momentum Check & Weekly Breakout Watchlists - newser.com
Aug PostEarnings: Can InspireMD Inc keep up with sector leadersJuly 2025 WrapUp & Safe Capital Growth Tips - khodrobank.com
Macro Review: Can InspireMD Inc keep up with sector leadersEarnings Trend Report & Precise Swing Trade Alerts - khodrobank.com
Chart overlay techniques for tracking InspireMD Inc.Swing Trade & Community Consensus Picks - newser.com
Order flow analysis tools used on InspireMD Inc.Trade Ideas & High Accuracy Swing Entry Alerts - newser.com
Reversal indicators forming on InspireMD Inc. stockQuarterly Market Review & Weekly Return Optimization Plans - newser.com
Published on: 2025-09-14 12:27:25 - newser.com
Has InspireMD Inc. found a price floorRate Cut & Fast Entry High Yield Tips - newser.com
Finanzdaten der InspireMD Inc.-Aktie (NSPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.50%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):